Table 1.

Sample characteristics by gender

	Women		Men		Test for group difference	Significance	Effect size
Variable	n	M (SD)	n	M (SD)	F	p	η2
Patient age	535	50.7 (10.9)	122	61.1 (14.3)	79.01	<0.001	0.108
Years since first diagnosis	533	4.9 (5.3)	122	5.3 (5.4)	0.53	0.468	0.001
Length of current relationship	515	19.8 (13.7)	118	25.7 (16.8)	16.55	<0.001	0.026
	n	%	n	%	χ2	p	φ
Cancer type:					519.19	<0.001	0.364
Breast	425	80	-	-
Gynecologic	45	8.5	-	-
Prostate	-	-	87	72.5
Genitourinary (other)	4	0.8	7	5.8
Hematological/Blood	23	4.3	14	11.7
Digestive/Gastrointestinal	11	2.1	4	3.3
Neurologic	6	1.1	4	3.3
Skin	8	1.5	2	1.7
Othera	9	1.7	2	1.7
Cancer classification:					10.52	.001	0.127
Sexual cancer type	474	89.3	94	78.3
Non-sexual cancer type	57	10.7	26	21.7
Stage of disease:					27.19	<0.001	0.188
No longer detectable/In remission	430	80.8	71	58.7
Receiving treatment	16	3.0	7	5.8
Otherb	86	16.2	43	35.5
Relationship status:					3.12	0.374	0.032
Partnered – Living together	414	77.4	96	78.7
Partnered – Not living together	34	6.4	10	8.2
Not in a relationship	76	14.2	16	13.1
Other/Not specified	11	2.1	-	-
Sexual identity:					405.16	<0.001	0.858
Heterosexual	434	96.7	92	91.1
Non Heterosexual	15	3.3	9	8.9
Current sexual relationship:
Yes	404	76.2	87	71.9
No	126	23.8	34	18.6	0.99	0.319	0.039

Note ^a “Other” includes: Respiratory/Thoracic, Head & Neck, various, each less than 1%; ^b “Other” includes: a new different cancer; active monitoring; outcome not specified; η2 eta-squared; φ Phi coefficient.